Lung Cancer (Non-Small Cell): Clinical Trials

16 trials for Lung Cancer (Non-Small Cell), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 recruiting, 6 not yet recruiting, 1 active not recruiting, 1 enrolling by invitation. 7 Phase 2, 6 Not applicable, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Recruiting 5, Not yet recruiting 2
Not applicable6Not yet recruiting 3, Active not recruiting 1, Enrolling by invitation 1, Recruiting 1
Phase 13Recruiting 2, Not yet recruiting 1

Follow Lung Cancer (Non-Small Cell): new trials by email Literature Review of Lung Cancer (Non-Small Cell) trials Research Report on Lung Cancer (Non-Small Cell)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Short- and Mid-term Therapeutic, Prognostic, and Societal Impact of Implementing Intraoperative Assessment of Pulmonary Resection Quality for Lung Cancer
QualitySurg List - Lung Cancer (Non-Small Cell)
Not applicableNot yet recruitingFondation Hôpital Saint-Joseph24002026-09-012026-09-18
Early Prophylactic Versus Late Salvage Recombinant Human Endostatin in Managing Radiosurgery-Induced Brain Injury for NSCLC Brain Metastases
Recombinant Human Endostatin (Endostar) - Lung Cancer (Non-Small Cell), Radiation
Phase 2Not yet recruitingJiangmen Central Hospital492026-09-012026-10-01
SL-28 for Advanced Solid Tumours
SL-28 - Head & Neck Cancer, Pancreas Carcinoma
Phase 1 / Phase 2RecruitingSecond Life Therapeutics602026-08-142026-09-15
Osimertinib Plus Capivasertib in NSCLC With PIK3CA/AKT1/PTEN Alterations Following Prior 1L Osimertinib
Capivasertib in combination with Osimertinib - Lung Cancer (NSCLC), Lung Cancer (Non-Small Cell)
Phase 1 / Phase 2Not yet recruitingShanxi Province Cancer Hospital532026-05-152026-03-24
Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC
Ivonescimab, carboplatin, pemetrexed - Lung Cancer (NSCLC), Lung Cancer Non-Small Cell Cancer (NSCLC)
Phase 2RecruitingMassachusetts General Hospital462026-05-012026-07-15
Immune Response to Immunotherapy in Lung Cancer: Study of Sputum and Blood Samples
Blood sample, sputum sample - Lung Cancer (NSCLC), Lung Cancer (Non-Small Cell)
Not applicableNot yet recruitingUniversity Hospital, Tours502026-04-012026-03-18
Effectiveness of a Multimodal Outpatient Supervised Physical Activity Program to Improve Tolerance and Efficacy of Chemotherapy in Adults With Breast, Lung and Colon Cancer
PREDU Exercise Program, Recommendation Exercise Program - Breast Cancer, Lung Cancer (Non-Small Cell)
Not applicableNot yet recruitingUniversity of Vic - Central University of Catalonia702026-04-012026-03-31
Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery
Observational Assessment - Lung Cancer (Non-Small Cell), Sarcopenia
RecruitingOndokuz Mayıs University1422026-03-152026-07-24
Development and Dissemination of Exercise Prescription and Intervention for Cancer Populations
structured exercise training - Cancer, Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma)
Not applicableRecruitingKaohsiung Medical University Chung-Ho Memorial Hospital1502026-03-122026-08-07
Association of Different Tidal Volumes and Postoperative Pulmonary Complications
Pulmonary Complications, Hypoxemia During Surgery
Not yet recruitingFirst Affiliated Hospital of Zhejiang University6502026-01-202026-01-28
A Phase II Study of SKB571 in Patients With Lung Cancer
SKB571 for injection - Lung Cancer (Non-Small Cell)
Phase 2RecruitingSichuan Kelun-Biotech Biopharmaceutical Co., Ltd.2952026-01-192026-05-12
IBI351 Plus Cetuximab β in Untreated Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
IBI351 combined with cetuximab β - Lung Cancer (Non-Small Cell)
Phase 2RecruitingGuangdong Association of Clinical Trials482025-11-032026-03-11
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
ADC - Prostate Cancer Castration-resistant Prostate Cancer, Breast Cancer
Phase 1 / Phase 2RecruitingMBrace Therapeutics1502025-09-032026-02-17
Evaluating the Feasibility and Preliminary Effects of BE+
Breathe Easier+ - Lung Cancer (Non-Small Cell), Self-management Behavior
Not applicableEnrolling by invitationUniversity of South Carolina202025-08-152025-10-09
Evaluation of Efficacy of Minimally Invasive Local Therapy for Lung Tumors and Its Impact on Breathing Function
Surgery, Ablation, SBRT - Lung Cancer (Non-Small Cell), Lung Metastases From Any Primary
Not applicableActive not recruitingAurimas Macionis682022-11-222025-12-09
Cardiac MRI Biomarker Testing (GCC 1618)
Complete Cardiac Magnetic Resonance Imaging (MRI) - Breast Cancer, Lung Cancer (Non-Small Cell)
TerminatedUniversity of Maryland, Baltimore62018-02-012022-10-13

Narrower conditions

Carcinoma, Non-Small-Cell Lung (16)  ·  Breast Neoplasms (5)  ·  Lung Neoplasms (5)  ·  Colorectal Neoplasms (3)  ·  Motor Activity (3)  ·  Colonic Neoplasms (2)  ·  Pancreatic Neoplasms (2)  ·  Prostatic Neoplasms (2)  ·  Adenocarcinoma of Lung (1)  ·  Brain Edema (1)  ·  Brain Injuries (1)  ·  Carcinoma, Hepatocellular (1)  ·  Endometrial Neoplasms (1)  ·  Esophageal Neoplasms (1)  ·  Head and Neck Neoplasms (1)

Broader conditions

Bronchial Neoplasms (16)  ·  Carcinoma, Bronchogenic (16)  ·  Lung Diseases (16)  ·  Neoplasms by Site (16)  ·  Respiratory Tract Diseases (16)  ·  Respiratory Tract Neoplasms (16)  ·  Thoracic Neoplasms (16)  ·  Neoplasms (15)  ·  Lung Neoplasms (11)  ·  Breast Diseases (5)  ·  Skin Diseases (5)  ·  Skin and Connective Tissue Diseases (5)  ·  Colonic Diseases (4)  ·  Digestive System Diseases (4)  ·  Digestive System Neoplasms (4)

Interventions

Anterior Temporal Lobectomy (1)  ·  Blood Specimen Collection (1)  ·  Carboplatin (1)  ·  Cryosurgery (1)  ·  Endostatins (1)  ·  Injections (1)  ·  Pemetrexed (1)  ·  Radiosurgery (1)  ·  Radiotherapy (1)  ·  Surgical Procedures, Operative (1)  ·  capivasertib (1)  ·  endostar protein (1)  ·  osimertinib (1)

Sponsors

Aurimas Macionis (1)  ·  First Affiliated Hospital of Zhejiang University (1)  ·  Fondation Hôpital Saint-Joseph (1)  ·  Guangdong Association of Clinical Trials (1)  ·  Jiangmen Central Hospital (1)  ·  Kaohsiung Medical University Chung-Ho Memorial Hospital (1)  ·  MBrace Therapeutics (1)  ·  Massachusetts General Hospital (1)  ·  Ondokuz Mayıs University (1)  ·  Second Life Therapeutics (1)  ·  Shanxi Province Cancer Hospital (1)  ·  Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (1)  ·  University Hospital, Tours (1)  ·  University of Maryland, Baltimore (1)  ·  University of South Carolina (1)

Countries

United States (4)  ·  China (3)  ·  France (2)  ·  Australia (1)  ·  Lithuania (1)  ·  Spain (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)

Top investigators

Elizabeth Nichols, MD (1)  ·  Jessics J Lin, MD (1)